Pages that link to "Q39341068"
Jump to navigation
Jump to search
The following pages link to Abnormal involuntary movements (AIMs) following pulsatile dopaminergic stimulation: severe deterioration and morphological correlates following the loss of locus coeruleus neurons. (Q39341068):
Displaying 26 items.
- Presynaptic Mechanisms of l-DOPA-Induced Dyskinesia: The Findings, the Debate, and the Therapeutic Implications (Q21129423) (← links)
- The locus coeruleus is directly implicated in L-DOPA-induced dyskinesia in parkinsonian rats: an electrophysiological and behavioural study (Q28477041) (← links)
- Norepinephrine loss produces more profound motor deficits than MPTP treatment in mice (Q30479999) (← links)
- Effects of noradrenergic denervation by anti-DBH-saporin on behavioral responsivity to L-DOPA in the hemi-parkinsonian rat. (Q33918393) (← links)
- Differential response of the central noradrenergic nervous system to the loss of locus coeruleus neurons in Parkinson's disease and Alzheimer's disease (Q34572608) (← links)
- Noradrenaline and Parkinson's disease (Q35013240) (← links)
- Effects of noradrenergic denervation on L-DOPA-induced dyskinesia and its treatment by α- and β-adrenergic receptor antagonists in hemiparkinsonian rats. (Q35624275) (← links)
- Effects of the beta-adrenergic receptor antagonist Propranolol on dyskinesia and L-DOPA-induced striatal DA efflux in the hemi-parkinsonian rat (Q35815701) (← links)
- Alterations in primary motor cortex neurotransmission and gene expression in hemi-parkinsonian rats with drug-induced dyskinesia. (Q36248918) (← links)
- Genetic or pharmacological blockade of noradrenaline synthesis enhances the neurochemical, behavioral, and neurotoxic effects of methamphetamine (Q37029888) (← links)
- Light and electron microscopic localization of alpha-1 adrenergic receptor immunoreactivity in the rat striatum and ventral midbrain (Q37217480) (← links)
- Alteration of daily and circadian rhythms following dopamine depletion in MPTP treated non-human primates (Q37509991) (← links)
- Intermittent Dopaminergic stimulation causes behavioral sensitization in the addicted brain and parkinsonism. (Q37629269) (← links)
- Pharmacological strategies for the management of levodopa-induced dyskinesia in patients with Parkinson's disease (Q38262418) (← links)
- Cerebrospinal fluid levels of catecholamines and its metabolites in Parkinson's disease: effect of l-DOPA treatment and changes in levodopa-induced dyskinesia (Q38937893) (← links)
- Circadian Clock Protein Content and Daily Rhythm of Locomotor Activity Are Altered after Chronic Exposure to Lead in Rat. (Q41823908) (← links)
- The emerging role of norepinephrine in cognitive dysfunctions of Parkinson's disease (Q42248817) (← links)
- The Neuroanatomy of the Reticular Nucleus Locus Coeruleus in Alzheimer's Disease (Q42363053) (← links)
- Deuterium-substituted L-DOPA displays increased behavioral potency and dopamine output in an animal model of Parkinson's disease: comparison with the effects produced by L-DOPA and an MAO-B inhibitor (Q42705333) (← links)
- An experimental study on intracerebroventricular transplantation of human amniotic epithelial cells in a rat model of Parkinson's disease (Q43059942) (← links)
- Effect of the additional noradrenergic neurodegeneration to 6-OHDA-lesioned rats in levodopa-induced dyskinesias and in cognitive disturbances (Q43285160) (← links)
- Alterations of the circadian system in Parkinson's disease patients. (Q48738662) (← links)
- Dyskinesia and brain-derived neurotrophic factor levels after long-term levodopa and nicotinic receptor agonist treatments in female mice with near-total unilateral dopaminergic denervation (Q59800025) (← links)
- The Effects of Amphetamine and Methamphetamine on the Release of Norepinephrine, Dopamine and Acetylcholine From the Brainstem Reticular Formation (Q64264112) (← links)
- Noradrenergic Modulation on Dopaminergic Neurons (Q88154378) (← links)
- The Noradrenergic System in Parkinson's Disease (Q93164939) (← links)